Ausgabe 6/2011
Inhalt (27 Artikel)
Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders
Sandip Basu, Thomas C. Kwee, Robert Gatenby, Babak Saboury, Drew A. Torigian, Abass Alavi
PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma
Shu-Hang Ng, Sheng-Chieh Chan, Tzu-Chen Yen, Chun-Ta Liao, Chin-Yu Lin, Joseph Tung-Chieh Chang, Sheung-Fat Ko, Hung-Ming Wang, Kai-Ping Chang, Kang-Hsing Fan
Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla
Julia Fruehwald-Pallamar, Christian Czerny, Marius E. Mayerhoefer, Benjamin S. Halpern, Christina Eder-Czembirek, Markus Brunner, Matthias Schuetz, Michael Weber, Laura Fruehwald, Andreas M. Herneth
Synchronous malignancies in patients with squamous cell carcinomas of the oral cavity
Feng-Yuan Liu, Chun-Ta Liao, Tzu-Chen Yen
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients
Caroline Rousseau, Anne Devillers, Mario Campone, Loïc Campion, Ludovic Ferrer, Christine Sagan, Myriam Ricaud, Boumédiène Bridji, Françoise Kraeber-Bodéré
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres
Alexander R. Haug, Volker Heinemann, Christiane J. Bruns, Ralf Hoffmann, Tobias Jakobs, Peter Bartenstein, Marcus Hacker
Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma
Rauf Haznedar, Sahika Z. Akı, Özgür U. Akdemir, Zübeyde N. Özkurt, Özcan Çeneli, Münci Yağcı, Gulsan T. Sucak, Mustafa Ünlü
Value of the radiolabelled GLP-1 receptor antagonist exendin(9–39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans
Beatrice Waser, Jean Claude Reubi
18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study
Erwin M. Wiegman, Jan Pruim, Jan F. Ubbels, Harry J. M. Groen, Johannes A. Langendijk, Joachim Widder
Prognostic value of interim FDG PET/CT in Hodgkin’s lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria
Pierre-Yves Le Roux, Thomas Gastinne, Steven Le Gouill, Emmanuel Nowak, Caroline Bodet-Milin, Solène Querellou, Beatrice Mahe, Viviane Dubruille, Nicolas Blin, Pierre Yves Salaun, Françoise Bodere-Kraeber
Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease
Makoto Isozaki, Yasushi Kiyono, Yoshikazu Arai, Takashi Kudo, Tetsuya Mori, Rikiya Maruyama, Ken-ichiro Kikuta, Hidehiko Okazawa
In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons
Christine DeLorenzo, Matthew S. Milak, Kathleen G. Brennan, J. S. Dileep Kumar, J. John Mann, Ramin V. Parsey
Iterative reconstruction or filtered backprojection for semi-quantitative assessment of dopamine D2 receptor SPECT studies?
Walter Koch, Christine Suessmair, Klaus Tatsch, Gabriele Pöpperl
The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease
Benjamin A. Thomas, Kjell Erlandsson, Marc Modat, Lennart Thurfjell, Rik Vandenberghe, Sebastien Ourselin, Brian F. Hutton
Prediction of left ventricular remodelling by radionuclide imaging
Constantinos D. Anagnostopoulos, Dennis V. Cokkinos
Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction
Valentina Berti, Roberto Sciagrà, Wanda Acampa, Francesca Ricci, Giampaolo Cerisano, Rosj Gallicchio, Carlo Vigorito, Alberto Pupi, Alberto Cuocolo
Vascular time-activity variation in patients undergoing 123I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake
Hein J. Verberne, Derk O. Verschure, G. Aernout Somsen, Berthe L. F. van Eck-Smit, Arnold F. Jacobson
Diagnostic cutoff points for 123I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson’s disease
África Muxí, Pilar Paredes, Ignacio Navales, Francesc Valldeoriola, Carles Gaig, Francisco Lomeña, Andres de la Cerda, Oriol Solà, Beatriz Domenech, Eduardo Tolosa, Francesca Pons
A new dimension of FDG-PET interpretation: assessment of tumor biology
Thomas C. Kwee, Sandip Basu, Babak Saboury, Valentina Ambrosini, Drew A. Torigian, Abass Alavi
Erratum to: Focus on time-of-flight PET: the benefits of improved time resolution
Maurizio Conti
Erratum to: Ultrafast nuclear myocardial perfusion imaging on a new gamma camera with semiconductor detector technique: first clinical validation
Ronny R. Buechel, Bernhard A. Herzog, Lars Husmann, Irene A. Burger, Aju P. Pazhenkottil, Valerie Treyer, Ines Valenta, Patrick von Schulthess, René Nkoulou, Christophe A. Wyss, Phillip A. Kaufmann
Lingual thyroid imaging with 123I SPECT/CT
Laetitia Vercellino, Nadia Ismaili Alaoui, Isabelle Faugeron, Nathalie Bérenger, Claire de Labriolle-Vaylet, Elif Hindié, Marie-Elisabeth Toubert
FDG PET/CT leads to the detection of metastatic involvement of the heart in non-Hodgkin’s lymphoma
A. Julian, T. Wagner, L. Ysebaert, V. Chabbert, P. Payoux
Guidelines for standard and diuretic renogram in children
Isky Gordon, Amy Piepsz, Rune Sixt